GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results:
Glaxosmithkline Pharmaceuticals Ltd Q3FY25; 400% rise in Profits
Categories
Pharmaceutical
ERIS Lifesciences Ltd Q3FY25; 14% fall in Profits
ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues
Dr Lal Pathlabs Ltd Q3FY25; 20% rise in Profits
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where
Sanofi India Ltd Q3FY25; 34% fall in Profits
Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for
Cipla Ltd Q3FY25; 47% rise in Profits
Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q3FY25
Pfizer Ltd Q3FY25; 2% fall in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Aurobindo Pharma Ltd Q3FY25; 10% fall in Profits
Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report
Astrazeneca Pharma India Ltd Q3FY25; 69% fall in Profits
AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca Pharma India
Ipca Laboratories Ltd Q3FY25; 25% rise in Profits
Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q3FY25 of ₹2,245.00
Alkem Laboratories Ltd Q3FY25; 6% rise in Profits
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical
Alembic Pharmaceuticals Ltd Q3FY25; 23% fall in Profits
Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company
Ajanta Pharma Ltd Q3FY25; 11% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Abbott India Ltd Q3FY25; 88% fall in Profits
Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within
ZYDUSLIFE Q3 2024-2025 Call Highlights: Profit Jump, Robust Margins & Expansion Plans!
Zydus Lifesciences Ltd., a leading Indian Pharmaceutical company, in its Q3 earnings call discussed strong performance across multiple segments, with US business
DIVISLAB Q3 2024-2025 Call Highlights: Expansion Plans, Generics Growth, and API Challenges!
Divi's Laboratories Ltd., an Indian multinational pharmaceutical company that manufactures and exports API's, Intermediates and Nutraceutical ingredients, in its Q3 earnings call
Granules India Ltd Q3FY25; 6% fall in Profits
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates
SUNPHARMA Q3 2024-2025 Call Highlights: India Leads, US Slows, Specialty Expands!
Sun Pharmaceutical Industries Ltd., the fourth largest specialty generic pharmaceutical company in the world, in its Q3 earnings call discussed about strong
Dr Reddys Laboratories Ltd Q3FY25; 2% rise in Profits
Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients
Glenmark Pharmaceuticals Ltd Q3FY25; 88% rise in Profits
Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80
CIPLA Q3 2024-2025 Call Highlights: EBITDA Growth, Launch Delays, & Market Strategies!
Cipla Ltd., a leading pharmaceutical company from India that manufactures and distributes branded medicines, generics and active pharmaceutical ingredients across the globe,
Jubilant Pharmova Ltd Q3FY25; 53% rise in Profits
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary